Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6936)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Della Corte C, Aghemo A, Colombo M. Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies. World J Gastroenterol 2013; 19(9): 1359-1371 [PMID: 23538741 DOI: 10.3748/wjg.v19.i9.1359] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i9/1359.htm |
| Number | Citing Articles |
| 1 |
Pierre Nahon, Jean‐Charles Nault. Constitutional and functional genetics of human alcohol‐related hepatocellular carcinoma. Liver International 2017; 37(11): 1591 doi: 10.1111/liv.13419
|
| 2 |
Meral Tuncbilek, Aslıgul Kucukdumlu, Ebru Bilget Guven, Duygu Altiparmak, Rengul Cetin-Atalay. Synthesis of novel 6-substituted amino-9-(β-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells. Bioorganic & Medicinal Chemistry Letters 2018; 28(3): 235 doi: 10.1016/j.bmcl.2017.12.070
|
| 3 |
Kasem Kulkeaw, Worakamol Pengsart. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases. Micromachines 2021; 12(7): 842 doi: 10.3390/mi12070842
|
| 4 |
Ding Shen, Jie Zheng, Xiping Cui, Yingshan Chen, Qiyi He, Rui Lv, Zhaoxia Li, Suqing Zhao. Analysis of cholyglycine acid as a biomarker for the early diagnosis of liver disease by fluorescence polarization immunoassay. Sensors and Actuators B: Chemical 2018; 256: 846 doi: 10.1016/j.snb.2017.10.013
|
| 5 |
Adriano M. Pellicelli, Pascal Vignally, Vincenzo Messina, Antonio Izzi, Ettore Mazzoni, Angelo Barlattani, Donato Bacca, Mario Romano, Fabrizio Mecenate, Tommaso Stroffolini, Caterina Furlan, Antonio Picardi, Umberto V. Gentilucci, Roberto Gulminetti, Maria E. Bonaventura, Roberto Villani, Cecilia D’Ambrosio, Amerigo Paffetti, Cristina Mastropietro, Massimo Marignani, Lucia Fondacaro, Giuseppe Cerasari, Arnaldo Andreoli, Giorgio Barbarini. Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma. Annals of Hepatology 2014; 13(4): 376 doi: 10.1016/S1665-2681(19)30844-0
|
| 6 |
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism. Cytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
|
| 7 |
Wan-Xia Yang, Yun-Yan Pan, Chong-Ge You. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1245072
|
| 8 |
Brian I. Carr, Petr Pancoska, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Identification of Two Clinical Hepatocellular Carcinoma Patient Phenotypes From Results of Standard Screening Parameters. Seminars in Oncology 2014; 41(3): 406 doi: 10.1053/j.seminoncol.2014.04.002
|
| 9 |
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
|
| 10 |
Min Qi, Yu Chen, Guo-Qiang Zhang, Yu-Juan Meng, Fu-Li Zhao, Jing Wang, Jun Ma. Clinical Significance of Preoperative Liver Stiffness Measurements in Primary HBV-Positive Hepatocellular Carcinoma. Future Oncology 2017; 13(30): 2799 doi: 10.2217/fon-2017-0281
|
| 11 |
Bendong Chen, Wenyan Zhou, Chaofeng Tang, Genwang Wang, Peng Yuan, Yawen Zhang, Sah Chandra Bhushan, Jinlong Ma, Junzhi Leng. Down-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820970668
|
| 12 |
Pierre Nahon, Angela Sutton, Marianne Ziol, Jessica Zucman-Rossi, Jean-Claude Trinchet, Nathalie Ganne-Carrié. Genetic Risk Markers for Hepatocellular Carcinoma in Patients with Alcoholic Liver Disease. Hepatic Oncology 2015; 2(1): 63 doi: 10.2217/hep.14.26
|
| 13 |
Maciej Adler, Licia Larocca, Francesca M. Trovato, Heather Marcinkowski, Yasmin Pasha, Simon D. Taylor-Robinson. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study. HPB 2016; 18(8): 678 doi: 10.1016/j.hpb.2016.05.005
|
| 14 |
Kaku Goto, Naoya Kato. MICA SNPs and the NKG2D system in virus-induced HCC. Journal of Gastroenterology 2015; 50(3): 261 doi: 10.1007/s00535-014-1000-9
|